JP2008013542A5 - - Google Patents

Download PDF

Info

Publication number
JP2008013542A5
JP2008013542A5 JP2007138744A JP2007138744A JP2008013542A5 JP 2008013542 A5 JP2008013542 A5 JP 2008013542A5 JP 2007138744 A JP2007138744 A JP 2007138744A JP 2007138744 A JP2007138744 A JP 2007138744A JP 2008013542 A5 JP2008013542 A5 JP 2008013542A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
bromhexine
ambroxol
loxoprofen
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007138744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008013542A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007138744A priority Critical patent/JP2008013542A/ja
Priority claimed from JP2007138744A external-priority patent/JP2008013542A/ja
Publication of JP2008013542A publication Critical patent/JP2008013542A/ja
Publication of JP2008013542A5 publication Critical patent/JP2008013542A5/ja
Pending legal-status Critical Current

Links

JP2007138744A 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物 Pending JP2008013542A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007138744A JP2008013542A (ja) 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006158130 2006-06-07
JP2007138744A JP2008013542A (ja) 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物

Publications (2)

Publication Number Publication Date
JP2008013542A JP2008013542A (ja) 2008-01-24
JP2008013542A5 true JP2008013542A5 (enrdf_load_stackoverflow) 2010-06-24

Family

ID=39070910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007138744A Pending JP2008013542A (ja) 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物

Country Status (1)

Country Link
JP (1) JP2008013542A (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010168373A (ja) * 2008-12-25 2010-08-05 Kowa Co ロキソプロフェン含有医薬組成物
JP2010215611A (ja) * 2009-01-28 2010-09-30 Kowa Co ロキソプロフェン含有医薬製剤
JP5624367B2 (ja) * 2009-05-28 2014-11-12 興和株式会社 ロキソプロフェン含有医薬製剤
JP5798735B2 (ja) * 2009-10-30 2015-10-21 興和株式会社 ロキソプロフェン含有医薬組成物
JP5897804B2 (ja) * 2010-02-26 2016-03-30 興和株式会社 ロキソプロフェン含有の医薬組成物
JP2012106977A (ja) * 2010-05-31 2012-06-07 Kowa Co ロキソプロフェンを含有する医薬組成物
MX337454B (es) * 2010-07-12 2016-03-07 Boehringer Ingelheim Int Composicion acuosa que contiene bromhexina.
JP5999892B2 (ja) * 2010-12-16 2016-09-28 第一三共ヘルスケア株式会社 ロキソプロフェンナトリウムとブロムヘキシンを含有する固形製剤
WO2013018765A1 (ja) * 2011-07-29 2013-02-07 興和株式会社 ロキソプロフェンを含有する医薬組成物
JP2016135745A (ja) * 2014-01-20 2016-07-28 興和株式会社 ロキソプロフェン含有去痰医薬組成物
JP6554168B2 (ja) * 2014-05-23 2019-07-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アンブロキソール塩酸塩を含む咳止めシロップ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172175A (ja) * 1999-12-14 2001-06-26 Taisho Pharmaceut Co Ltd 風邪用組成物

Similar Documents

Publication Publication Date Title
JP2008013542A5 (enrdf_load_stackoverflow)
FIC20230040I1 (fi) Koostumus käsittäen: sedatsuridiinia tai tämän farmaseuttisesti hyväksyttävää suolaa; ja desitabiinia.
NO2018029I1 (no) Alogliptin i kombinasjon med metformin, hver eventuelt i form av et farmasøytisk akseptabelt salt derav
IL193702A (en) Pharmaceutical preparation containing human embryonic stem cells, methods of manufacture and use thereof
NO2017002I1 (no) Cobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav, spesielt atazanavirsulfat
JP2007527914A5 (enrdf_load_stackoverflow)
HUE064677T2 (hu) Citidin-analógokat tartalmazó orális készítmények és eljárások azok alkalmazására
IL193467A0 (en) Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
IL190137A0 (en) Crystals of laquinimod sodium, and process for the manufacture thereof
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
EP2124921A4 (en) SULFONYL SEMI-CARBAZIDES, CARBONYL SEMI-CARBAZIDS, SEMI-CARBAZIDS AND UREA, PHARMACEUTICAL COMPOSITIONS THEREOF, AND PROCESS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING ARENAVIRUS-ASSOCIATED INFECTIONS
JP2010510212A5 (enrdf_load_stackoverflow)
JP2009536652A5 (enrdf_load_stackoverflow)
ZA200800408B (en) Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
AP2413A (en) 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other disease.
CL2013002905A1 (es) Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares.
HUE046349T2 (hu) Kompozíciók rákos sejtek kezelésére, és ezek szintézise
CL2007000680A1 (es) Compuesto cristalino (5s)-5-[4(cloro-piridin-2-iloxi)-piperidin-1-sulfonilmetil]-5-metil-imidazolidin-2,4-diona, forma g; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de epoc.
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina
EP2168584A4 (en) PHARMACEUTICAL COMPOSITION COMBINING TRIAZOLOBENZODIAZEPINE AND SELECTIVE SEROTONIN RECAPTURE SELECTIVE INHIBITOR
JP2008536808A5 (enrdf_load_stackoverflow)
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
JP2008519810A5 (enrdf_load_stackoverflow)
IL177750A0 (en) Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
ZA200802774B (en) Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake